Phase 2 Fatigue Clinical Trials
31 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 31 trials
Recruiting
Phase 2
Repetitive Transcranial Magnetic Stimulation, a Form of Non-invasive Brain Stimulation, as a Possible Treatment for Post-stroke Fatigue.
FatigueStrokeStroke, Chronic
VA Office of Research and Development60 enrolled1 locationNCT05584124
Recruiting
Phase 2
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
CancerFatigueHypogonadism, Male
Seattle Institute for Biomedical and Clinical Research230 enrolled3 locationsNCT04301765
Recruiting
Phase 2
Transcranial Direct Current Stimulation for Post-stroke Fatigue
FatigueStroke Rehabilitaion
Weill Medical College of Cornell University24 enrolled1 locationNCT05816603
Recruiting
Phase 2
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Myalgic EncephalomyelitisChronic Fatigue Syndrome
Weill Medical College of Cornell University95 enrolled1 locationNCT04542161
Recruiting
Phase 2
Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors
Breast CancerProstate CancerCancer-related Fatigue
University of Colorado, Denver134 enrolled2 locationsNCT07001241
Recruiting
Phase 1Phase 2
Modafinil to Improve Fatiguability
Cancer-related Cognitive DifficultiesFatigueCancer-related Problem/Condition
Ottawa Hospital Research Institute40 enrolled1 locationNCT05333250
Not Yet Recruiting
Phase 2
A Study of Safety and Efficacy of STIR-101 in Participants Experiencing Symptoms of Long Covid
Chronic Fatigue Syndrome
STIR Pharma Ltd40 enrolled1 locationACTRN12625001372471
Recruiting
Phase 2
Ketamine for Multiple Sclerosis Fatigue
Multiple Sclerosis Fatigue
Johns Hopkins University110 enrolled1 locationNCT05378100
Recruiting
Phase 2
Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer
FatigueInflammation
University of Rochester40 enrolled1 locationNCT06295588
Recruiting
Phase 2Phase 3
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
CancerDepressionSleep+2 more
M.D. Anderson Cancer Center188 enrolled1 locationNCT05474846
Recruiting
Phase 2Phase 3
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
FatigueMetastatic Cancers
M.D. Anderson Cancer Center240 enrolled1 locationNCT06085716
Recruiting
Phase 2
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
SurvivorshipNeoplasmsFatigue+3 more
University of Maryland, Baltimore96 enrolled1 locationNCT06482515
Recruiting
Phase 2
Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
Multiple SclerosisMultiple Sclerosis Fatigue
Johns Hopkins University46 enrolled1 locationNCT06170970
Recruiting
Phase 2
PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients
Cancer-related Fatigue
PhytoHealth Corporation36 enrolled1 locationNCT05440227
Recruiting
Phase 2
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
Insulin ResistanceChronic Kidney DiseasesFatigue+4 more
University of California, Davis80 enrolled2 locationsNCT04984226
Recruiting
Phase 2
Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
National Center of Neurology and Psychiatry, Japan30 enrolled1 locationNCT06952413
Recruiting
Phase 2
Pioglitazone Therapy Targeting Fatigue in Breast Cancer
Breast CancerMuscle Fatigue
West Virginia University30 enrolled1 locationNCT05013255
Recruiting
Phase 2
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
Hypogonadism, MaleFatigue Syndrome, Chronic
Seattle Institute for Biomedical and Clinical Research240 enrolled2 locationsNCT04049331
Recruiting
Phase 2Phase 3
TRI-ME: Trimetazidine to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A double-blind, randomised, placebo-controlled efficacy trial
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Deakin University126 enrolled1 locationACTRN12625000095460
Recruiting
Phase 2
The Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults
FatigueCancer, Treatment-Related
Canada Royal Enoch Phytomedicine Co., Ltd.72 enrolled1 locationNCT05664009